Acute radiodermatitis
ICD-10 L58.0 is a billable code used to indicate a diagnosis of acute radiodermatitis.
Acute radiodermatitis is an inflammatory skin condition that occurs as a result of exposure to ionizing radiation, commonly seen in patients undergoing radiation therapy for cancer treatment. Clinically, it presents with erythema, edema, and desquamation of the skin, often accompanied by symptoms such as itching and pain. The anatomy involved primarily includes the epidermis and dermis, where radiation-induced damage leads to cellular apoptosis and inflammatory responses. Disease progression typically follows a dose-dependent pattern, with symptoms appearing within days to weeks post-exposure, peaking at around two weeks, and gradually resolving over several weeks. Diagnostic considerations include a thorough patient history of radiation exposure, clinical examination of the affected skin, and ruling out other dermatological conditions that may mimic radiodermatitis. In severe cases, secondary infections may occur, necessitating further evaluation and management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
L58.0 specifically covers acute radiodermatitis resulting from ionizing radiation exposure, primarily in patients receiving radiation therapy. It does not include dermatitis from other causes.
L58.0 should be used when the dermatitis is directly linked to acute radiation exposure. If the dermatitis is chronic or due to other causes, different codes such as L58.1 or L30.9 may be more appropriate.
Documentation should include a detailed history of radiation exposure, clinical findings of the skin condition, treatment plans, and any relevant imaging or laboratory results that support the diagnosis.
